Диссертация (1174263), страница 20
Текст из файла (страница 20)
69. – P.907 – 910.13569.Aschbacher R. Molecular epidemiology of methicillin-resistant from bacteraemiain northern [Text] / R. Aschbacher, B. Pichon, M. Wootton, [et al.] // Italy. Infez.Med. 2012. – Vol.20. – P.256-264.70.Cetinkol Y. The investigation of oxacillinase/metallo-beta-lactamase genes andclonal analysis in carbapenem-resistant Klebsiella pneumoniae [Text] / Y.Cetinkol, A.A. Yildirim, M. Telli, [et al.] // Infez.
Med. – 2016. – Vol.24. - P.4853.71.Calitri C. Extended - Spectrum Beta Lactamase-producing Enterobacteriaceaeamong the pediatric population: who is at risk and why? Results from a singlecentre prospective study [Text] / C. Calitri, C. Scolfaro, S. Colombo, [et al.] //Infez. Med. - 2016. – Vol.24. - P. 318-325.72.Capone A. High rate of colistin resistance among patients with carbapenemresistant Klebsiella pneumoniae infection accounts for an excess of mortality[Text] / A.
Capone, M. Giannella, D. Fortini, [et al.] // Clinical Microbiology andInfection. – 2013. – Vol. 19. – P. 23 – 30.73.Cuzon G. Outbreak of OXA-48 - Positive Carbapenem-Resistant Klebsiellapneumoniae Isolates in France [Text] / G. Cuzon, J.
Ouanich, R. Gondret, [et al.]// Antimicrobal agents and chemotherapy. – 2011. – Vol. 55. - N. 5. - P. 2420 –2423.74.Deveci O. Carbapenem resistance in Acinetobacter baumannii: where is it heading?[Text] / O. Deveci, T. Dal, R. Tekin, [et al.] // Infez. Med. – 2013. – Vol. 21. –P.211-215.75.Metan G. A nightmare for haematology clinics: extensively drug-resistant (XDR)Acinetobacter baumannii [Text] / G. Metan, C.
Pala, L. Kaynar, [et al.] // Infez.Med. – 2014 – Vol.22. – P.277-282.13676.Wang F. CHINET 2012 surveillance of bacterial resistance in China [Text] / F.Wang, D. Zhu, F. Hu, [et al.] //China J. Infect. Chemother. - 2013. – Vol.13. –P.321-330.77.Owlia P. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: aglobal threat to burn patients [Text] / P. Owlia, L. Azimi, A. Gholami, [et al.] //Infez.
Med. - 2012. – Vol.20. – P.182-7.78.Antunes L.C. Acinetobacter baumannii: evolution of a global pathogen [Text] /L.C. Antunes, P. Visca, K.J. Towner // Pathog. Dis. – 2014. – Vol.71. - P. 292-301.79.Buccoliero G. Rapid spread of multiresistant Acinetobacter baumannii isolates inintensive care units (ICUs) and in vitro activity of colistin and tigecycline [Text] /G. Buccoliero, E. Morelli, G. Lonero, [et al.] // Infez. Med. - 2012. - Vol.20. P.296-298.80.Abbott I. Carbapenem Resistance in Acinetobacter baumannii [Text] / I.
Abbott,G.M. Cerqueira, S. Bhuiyan, [et al.] // Anti-infection Therapy. – 2013. – Vol. 11,N. 4. – P. 395 – 409.81.Cai Y. Colistin resistance of Acinetobacter baumannii: clinical reports,mechanisms and antimicrobial strategies [Text] / Y. Cai, D. Chai, R. Wang, [et al.]// Journal of Antimicrobial Chemotherapy. – 2012.
– Vol. 67, N. 7. – P. 1607–1615.82.Lila G. The prevalence and resistance patterns of Pseudomonas aeruginosa in atertiary care hospital in Kosovo [Text] / G. Lila, G. Mulliqi-Osmani, R. Bajrami,[et al.] // Infez. Med. - 2017. – Vol.25. - P.21-26.83.Potron A. Emerging broad-spectrum resistance in Pseudomonas aeruginosa andAcinetobacter baumannii: Mechanisms and epidemiology [Text] / A. Potron, L.Poirel, P. Nordmann // Int. J. Antimicrob. Agents.
- 2015. – Vol.45. – P.568-585.13784.Castanheira M. Epidemiology and carbapenem resistance mechanisms ofcarbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009–11in 14 European and Mediterranean countries [Text] / M. Castanheira, L.M.Deshpande1, A. Costello [et al.] // Journal of Antimicrobial Chemotherapy. – 2014.– Vol. 69. N.
7. – P. 1 – 11.85.Lin K.Y. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence,risk factors, and impact on outcome of infections [Text] / K.Y. Lin, T.L.Lauderdale, J.T. Wang, [et al.] // J. Microbiol. Immunol. Infect. – 2016. – Vol.49.– P. 52-59.86.Ly N.S.
Colistin and doripenem combinations against Pseudomonas aeruginosa:profiling the time course of synergistic killing and prevention of resistance [Text]/ N.S. Ly, J.B. Bulitta, G.G. Rao, [et al.] //J. Antimicrob. Chemother. 2015. –Vol.70. – P.1434-1442.87.Sievert D.M. Antimicrobial-resistant pathogens associated with healthcareassociated infections: summary of data reported to the National Healthcare SafetyNetwork at the Centers for Disease Control and Prevention, 2009-2010 [Text] /D.M. Sievert, P.
Ricks, J.R. Edwards, [et al.] // Infect. Control Hosp. Epidemiol. –2013. – Vol.34. – P. 1-14.88.Huh K. Risk factors and treatment outcomes of bloodstream infection caused byextended-spectrum cephalosporin-resistant Enterobacter species in adults withcancer [Text] / K. Huh, C.I. Kang, J. Kim, [et al.] // Diagn. Microbiol. Infect. Dis.– 2014. – Vol.78. – P.172-177.89.Tedesco Maiullari R.M. Enterobacteria producers of extended-spectrum betalactamase in a hospital from Venezuela [Text] / R.M. Tedesco Maiullari, A.Guevara // Infez. Med.
– 2012. – Vol.20. – P.93-99.13890.Schwaber M.J. Treatment with a broad-spectrum cephalosporin versuspiperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporinresistant Enterobacter species [Text] / M.J. Schwaber, C.S. Graham, B.E. Sands,[et al.] // Antimicrob. Agents Chemother. – 2003. – Vol.47. – P. 1882-1886.91.Horan T.C. CDC/NHSN surveillance definition of health care-associated infectionand criteria for specific types of infections in the acute care setting [Text] / T.C.Horan, M.
Andrus, M.A. Dudeck // Am J Infect Control. – 2008. – Vol. 36, N. 5. –P. 309–32.92.McClelland S III. Postoperative central nervous system infection: incidence andassociated factors in 2111 neurosurgical procedures [Text] / S. III McClelland,W.A.Hall // Clin Infect Dis. – 2007.
– Vol.45. -N.1. P.55–59.93.Yang K.Y. Postneurosurgical nosocomial bacterial brain abscess in adults [Text] /K.Y. Yang, W.N. Chang, J.T. Ho, [et al.] // Infection 2006. -Vol.34. -N.5. - P.247–251.94.Nathoo N. Brain abscess: management and outcome analysis of a computedtomography era experience with 973 patients [Text] / N. Nathoo, S.S. Nadvi, P.K.Narotam, [et. al] // World Neurosurg. - 2011. – Vol. 75. - P.716-726.95.Tattevin P.
Bacterial brain abscesses: a retrospective study of 94 patients admittedto an intensive care unit (1980 to 1999) [Text] / P. Tattevin, F. Bruneel, B. Clair,[et al.] // Am J Med. – 2003. -Vol. 115. - P.143–6.96.Rath T.J. Imaging of cerebritis, encephalitis, and brain abscess [Text] / T.J. Rath,M. Hughes, M. Arabi, [et al.] // Neuroimaging Clin N Am.
– 2012. – Vol.22. – P.585–607.13997.Hall W.A. The surgical management of infections involving the cerebrum [Text] /W.A. Hall, C.L. Truwit // Neurosurgery. - 2008 - Vol. 62. - P. 519–530.98.Nathoo N. Intracranial subdural empyemas in the era of computed tomography: areview of 699 cases [Text] / N. Nathoo, S.S. Nadvi, J.R.
van Dellen, [et al.] //Neurosurgery. – 1999. – Vol.44. -N.3. -P. 529–535.99.Davis D.P. The clinical presentation and impact of diagnostic delays on emergencydepartment patients with spinal epidural abscess [Text] / D.P. Davis, R.M. Wold,R.J. Patel, [et al] // J Emerg Med. – 2004. - Vol.26. – P.285–291.100. Korinek A.M. Risk factors for adult nosocomial meningitis after craniotomy: roleof antibiotic prophylaxis [Text] / A.M.
Korinek, T. Baugnon, J.L. Golmard, [et al.]// Neurosurgery. - 2006. – Vol.59, N. 1. – P. 126–33.101. Popugaev K.A. Risk factors of postoperative meningitis in patients with chiasmsellar tumors [Text] / K.A. Popugaev, I.A. Savin, O.N. Ershova, [et al.] //Anesteziol Reanimatol. – 2014. – Vol. 2. – P. 10 – 4.102. Varatharaj A. The blood-brain barrier in systemic inflammation [Text] / A.Varatharaj, I. Galea // Brain Behav Immun. – 2016. – Vol. 16. - P. 889 – 1591.103.
Mazeraud A. Neuroanatomy and Physiology of Brain Dysfunction in Sepsis [Text]/ A. Mazeraud, Q. Pascal, F. Verdonk, [et al.] // Clin Chest Med. - 2016. – Vol.37.– P. 333 – 45.104. Williams S.T. Pathophysiology of encephalopathy and delirium [Text] / S.T.Williams // J Clin Neurophysiol. – 2013. – Vol.30. – P. 435 – 7.105. Wang G. Sepsis associated encephalopathy is an independently risk factor fornosocomial coma in patients with supratentorial intracerebral hemorrhage: a140retrospective cohort study of 261 patients [Text] / G. Wang, S.
Wang, Y. Zhou, [etal.] // Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. – 2016. - Vol. 28. – P. 723 – 8.106. Bleck T.P. Less common etiologies of status epilepticus [Text] / T.P. Bleck //Epilepsy Curr. – 2010. – Vol. 10. – N.2. – P.31–3.107. Singer M. The Third International Consensus Definitions for Sepsis and SepticShock (Sepsis-3) [Text] / M.
Singer, C.S. Deutschman, C.W. Seymour [et al.] //JAMA – 2016. – Vol. 315. - N.8. - P.801–810.108. Pytel P. Pathogenesis of septic encephalopathy [Text] / P. Pytel, J.J. Alexander //Curr Opin Neurol. - 2009 - Vol. 22 - P. 283–287.109. Siami S. The encephalopathy in sepsis [Text] / S. Siami, D.
Annane, T. Sharshar[et al.] // Crit Care Clin 2008 - Vol. 24 - P. 67–82.110. Zhu S.Z. Huperzine A protects sepsis associated encephalopathy by promoting thedeficient cholinergic nervous function [Text] / S.Z. Zhu, W.P. Huang, L.Q. Huang,[et al.] // Neurosci Lett.
– 2016, - Vol. 631. – P. 70 – 8.111. Karthikeyan A. MicroRNAs: Key players in microglia and astrocyte mediatedinflammation in CNS pathologies [Text] / A. Karthikeyan, R. Patnala, S.P. Jadhav,[et al.] // Curr Med Chem. – 2016. – Vol. 23. – N.30. – P.3528-3546112. Hoogland I.C.M. Systemic inflammation an microglial ativation systematic reviewof animal experiments [Text] / I.C.M. Hoogland, C. Houbolt, van Westerloo [et al.]// J Neuroinflammation.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
